Dermata Therapeutics, Inc.(DRMA)

Biotechnology · San Diego, CA

$1.13+0.02 (+1.80%)

Delayed quote: Oct 6, 2026, 2:39 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T18:56:32.802Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:56:32.802Z.

Quote observation: 2026-10-06T18:39:55.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -4.39
Quote price: 1.13

FMP input reference: 7afec7845e5c1de7d6a7da79415c7f2016586588c7dc262303e5dc1b6d25f1da

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

DRMA Earnings Yield Metrics

EARNINGS YIELD

N/A

DRMA Competitors' Earnings Yield

DRMA

Dermata Therapeutics, Inc.

Current

Market Cap

$4.55M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PMCB

PharmaCyte Biotech, Inc.

vs DRMA

Market Cap

$4.59M

Earnings Yield

N/A

TTM Avg

106.12%

3Y Avg

106.12%

5Y Avg

106.12%

CALC

CalciMedica, Inc.

vs DRMA

Market Cap

$4.63M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGMS

Bio Green Med Solution, Inc.

vs DRMA

Market Cap

$4.72M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLGN

CollPlant Biotechnologies Ltd.

vs DRMA

Market Cap

$4.28M

Earnings Yield

N/A

TTM Avg

1.27%

3Y Avg

1.27%

5Y Avg

1.27%

AIDX

20/20 Biolabs Inc.

vs DRMA

Market Cap

$4.33M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XBIO

Xenetic Biosciences, Inc.

vs DRMA

Market Cap

$5.06M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LEXX

Lexaria Bioscience Corp.

vs DRMA

Market Cap

$4.95M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRI

GRI Bio, Inc.

vs DRMA

Market Cap

$4.13M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PCSA

Processa Pharmaceuticals, Inc.

vs DRMA

Market Cap

$4.11M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Dermata Therapeutics, Inc. (DRMA)	$4.55M	N/A	N/A	N/A	N/A
PharmaCyte Biotech, Inc. (PMCB)vs ›	$4.59M	N/A	106.12%	106.12%	106.12%
CalciMedica, Inc. (CALC)vs ›	$4.63M	N/A	N/A	N/A	N/A
Bio Green Med Solution, Inc. (BGMS)vs ›	$4.72M	N/A	N/A	N/A	N/A
CollPlant Biotechnologies Ltd. (CLGN)vs ›	$4.28M	N/A	1.27%	1.27%	1.27%
20/20 Biolabs Inc. (AIDX)vs ›	$4.33M	N/A	N/A	N/A	N/A
Xenetic Biosciences, Inc. (XBIO)vs ›	$5.06M	N/A	N/A	N/A	N/A
Lexaria Bioscience Corp. (LEXX)vs ›	$4.95M	N/A	N/A	N/A	N/A
GRI Bio, Inc. (GRI)vs ›	$4.13M	N/A	N/A	N/A	N/A
Processa Pharmaceuticals, Inc. (PCSA)vs ›	$4.11M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

DRMA Earnings Yield Metrics

DRMA Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics